Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Journal of Inorganic Biochemistry|June 29, 2016
Anticancer metal drugs and immunogenic cell deathAlessio Terenzi, Christine Pirker, Bernhard K Keppler, et al.
Molecular Cancer|March 18, 2011
Overexpression of Aurora-A in primary cells interferes with S-phase entry by diminishing Cyclin D1 dependent activitiesFlorian Jantscher, Christine Pirker, Christoph-Erik Mayer, et al.
Biochemical and Biophysical Research Communications|March 30, 2004
SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitorsElisabeth Steiner, Klaus Holzmann, Christine Pirker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastasesKatharina Schmid, Natalie Oehl, Fritz Wrba, et al.
Journal of Cell Science|January 19, 2006
The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signalsElisabeth Steiner, Klaus Holzmann, Christine Pirker, et al.
Chemical Reviews|November 30, 2018
Metal Drugs and the Anticancer Immune ResponseBernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Oncology Letters|February 14, 2018
Dynamics of CRISPR/Cas9-mediated genomic editing of the <i>AXL</i> locus in hepatocellular carcinoma cellsIrene Scharf, Lisa Bierbaumer, Heidemarie Huber, et al.
Melanoma Research|September 27, 2003
Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genesChristine Pirker, Klaus Holzmann, Sabine Spiegl-Kreinecker, et al.
Experimental Dermatology|November 20, 2010
Response of experimental malignant melanoma models to the pan-Aurora kinase inhibitor VE-465Christine Pirker, Daniela Lötsch, Sabine Spiegl-Kreinecker, et al.
Pageof 9